Session Details
[Pe-038]English Poster Session 038 Parkinson's disease (Pharmacotherapy 3)
Fri. May 23, 2025 5:15 PM - 6:35 PM JST
Fri. May 23, 2025 8:15 AM - 9:35 AM UTC
Fri. May 23, 2025 8:15 AM - 9:35 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chairs: Makoto Shiraishi（Department of Neurology, St. Marianna University School of Medicine, Japan）, Shinsuke Fujioka（International University of Health and Welfare Department of Neurology, Japan）
[Pe-038-1]Background Factors in Parkinson's Disease Patients with a Favorable Response to MAO-B Inhibitors
Naohito Ito1, Junnosuke Ozawa1, Kaoru Matsuoka1, Tatsuya Nakanishi1,2, Takahide Wada1, Atsushi Ishida1,2, Tatsunori Oguchi2,3, Mayumi Tsuji3, Yuji Kiuchi2,3, Hidetomo Murakami1 (1.Department of Neurology, School of Medicine, Showa University, Japan, 2.Department of Pharmacology, School of Medicine, Showa University, Japan, 3.Pharmacological Research Center, Showa University, Japan)
[Pe-038-2]Medication dose at the onset of ON/OFF fluctuations and dyskinesias in Parkinson's disease
Yasushi Osaki, Yukari Morita, Sho Ohtsuru, Tomohiro Shogase, Yoshimoto Daiji, Miyoshi Toshimasa, Tatsuya Ikeda, Yu Hashimoto, Takuya Matsushita (Department of Neurology, Kochi Medical School Hospital, Japan)
[Pe-038-3]The Effects of Synthetic Danshen Compound in Parkinson's Disease: Roles of Mitophagy and ER Stress
Hui-chen Ku1, Evelyn Cheng2, Jia-fang Chung1, Ching-feng Cheng1,3,4 (1.Department of Pediatrics, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan, 2.Department of Biology, University of Washington, USA, 3.Institute of Biomedical Sciences, Academia Sinica, Taiwan, 4.Department of Pediatrics, Tzu Chi University, Taiwan)
[Pe-038-4]Antiparkinsonian role of silver nanoparticles synthesized from Eclipta prostrate in Animal Model
Pardeep Kumar, Ranbir Singh (Shri Maha maya vaishnav devi research institute, India)